3SBio Inc. (ADR) (NASDAQ:SSRX) was in 9 hedge funds’ portfolio at the end of December. SSRX has seen an increase in hedge fund interest recently. There were 8 hedge funds in our database with SSRX positions at the end of the previous quarter.
In today’s marketplace, there are dozens of methods investors can use to analyze the equity markets. A duo of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best investment managers can outpace the broader indices by a superb amount (see just how much).
Just as key, positive insider trading sentiment is a second way to parse down the world of equities. Just as you’d expect, there are plenty of reasons for an executive to cut shares of his or her company, but only one, very clear reason why they would initiate a purchase. Various empirical studies have demonstrated the market-beating potential of this method if investors know where to look (learn more here).
Consequently, we’re going to take a peek at the latest action encompassing 3SBio Inc. (ADR) (NASDAQ:SSRX).
What does the smart money think about 3SBio Inc. (ADR) (NASDAQ:SSRX)?
At year’s end, a total of 9 of the hedge funds we track held long positions in this stock, a change of 13% from the previous quarter. With hedge funds’ sentiment swirling, there exists a few notable hedge fund managers who were increasing their stakes meaningfully.
Of the funds we track, OrbiMed Advisors, managed by Samuel Isaly, holds the largest position in 3SBio Inc. (ADR) (NASDAQ:SSRX). OrbiMed Advisors has a $28.5 million position in the stock, comprising 0.9% of its 13F portfolio. On OrbiMed Advisors’s heels is Jerome Pfund and Michael Sjostrom of Sectoral Asset Management, with a $12.5 million position; 0.4% of its 13F portfolio is allocated to the stock. Other hedgies that hold long positions include Jim Simons’s Renaissance Technologies, Donald Chiboucis’s Columbus Circle Investors and John Arnold’s Centaurus Advisors.
As industrywide interest jumped, specific money managers were leading the bulls’ herd. Centaurus Advisors, managed by John Arnold, established the biggest position in 3SBio Inc. (ADR) (NASDAQ:SSRX). Centaurus Advisors had 2.4 million invested in the company at the end of the quarter.
What do corporate executives and insiders think about 3SBio Inc. (ADR) (NASDAQ:SSRX)?
Insider trading activity, especially when it’s bullish, is particularly usable when the company we’re looking at has seen transactions within the past six months. Over the last half-year time frame, 3SBio Inc. (ADR) (NASDAQ:SSRX) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).
Let’s also take a look at hedge fund and insider activity in other stocks similar to 3SBio Inc. (ADR) (NASDAQ:SSRX). These stocks are Obagi Medical Products, Inc. (NASDAQ:OMPI), Vical Incorporated (NASDAQ:VICL), Osiris Therapeutics, Inc. (NASDAQ:OSIR), Novavax, Inc. (NASDAQ:NVAX), and XenoPort, Inc. (NASDAQ:XNPT). This group of stocks are the members of the biotechnology industry and their market caps match SSRX’s market cap.
| Company Name | # of Hedge Funds | # of Insiders Buying | # of Insiders Selling |
| Obagi Medical Products, Inc. (NASDAQ:OMPI) | 7 | 0 | 0 |
| Vical Incorporated (NASDAQ:VICL) | 8 | 5 | 0 |
| Osiris Therapeutics, Inc. (NASDAQ:OSIR) | 1 | 1 | 3 |
| Novavax, Inc. (NASDAQ:NVAX) | 5 | 1 | 0 |
| XenoPort, Inc. (NASDAQ:XNPT) | 13 | 0 | 0 |
With the results demonstrated by the aforementioned research, everyday investors should always monitor hedge fund and insider trading activity, and 3SBio Inc. (ADR) (NASDAQ:SSRX) is no exception.
